Role of isoxsuprine as a tocolytic agent in the management of preterm labor in Indian clinical practice
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20240024Keywords:
Tocolytics, Isoxsuprine, Premature birthAbstract
Preterm labor (PTL) is one of the prime etiological factors responsible for neonatal disease burden and fatality. Despite recent advances in neonatal care and obstetrics, the occurrence of PTL is increasing, and women who have previously experienced spontaneous PTL are more susceptible to PTL in the future. Currently, PTL is diagnosed based on regular uterine contractions, their frequency, and associated cervical changes. Antenatal corticosteroids and magnesium sulfate interventions can improve neonatal outcomes. Tocolytic medications can temporarily delay delivery to facilitate the administration of corticosteroids. Isoxsuprine is a preferred tocolytic agent because it significantly increases the average latency period, delays delivery by >48 hours, and is associated with improved perinatal outcomes. This review examines recommendations from expert gynecologists for the management of PTL in the Indian clinical setting. The experts opined that intravenous administration with Isoxsuprine provides the advantage of dose titration, thereby minimizing potential side effects. Moreover, continuation of oral isoxsuprine till 37 weeks as maintenance therapy was advised as per literature evidence and experts’ clinical experience. Furthermore, concomitant administration of nifedipine and magnesium sulfate was not recommended as this can lead to neuromuscular blockade and fatal respiratory arrest, due to the action of both molecules on the blockage of calcium channels. The experts also emphasized the significance of considering individual experiences with various treatment options and identified specific obstacles and difficulties related to the utilization of isoxsuprine as a tocolytic agent, thereby offering valuable insights into potential approaches to overcome these challenges.
References
Sameshima H. Definition and diagnosis of PTL. In: Preterm labor and delivery. 1st ed. Singapore: Springer. 2020;7-15.
Federation of Obstetrics and Gynecological Societies of India (FOGSI). Preterm Labor. In: TOG -6 Algorithms, TOG 6th Conclave. 2019;25-39.
Obimbo M, Gaw S. Pre-term Labor: Suspected and confirmed. In: Glob. libr. women’s med. The Continuous Textbook of Women’s Medicine Series-Obstetrics Module vol 2. FIGO. 2021;1756-2228.
Sukladas S, Prasad US. A prospective study to assess the neonatal mortality and morbidity associated with PTL and delivery in a tertiary care hospital. Ann Int Med Den Res. 2016;2(2):116-9.
SMFM Research Committee; Grantz KL, Kawakita T, Lu YL, Newman R, Berghella V et al. SMFM Special Statement: State of the science on multifetal gestations: unique considerations and importance. Am J Obstet Gynecol. 2019;221(2):B2-12.
Santi E, Nencini G, Cerni A, Greco P, Spelzini F, Tormettino B et al. The PLART study: Incidence of PTL and adverse pregnancy outcomes after assisted reproductive techniques-A retrospective cohort study. Arch Gynecol Obstet. 2019;300(4):911-6.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 171: Management of preterm labor. Obstet Gynecol. 2016a;128(4):e155-64.
FOGSI Focus-Prevention of Pre-Term Labour – 2017 The Federation of Obstetric and Gynecological Societies of India. 2017. Available at: https://www.fogsi.org/fogsi-focus-prevention-of-pre-term-labour-2017/. Accessed on 6 June 2023.
CDSCO. Available at: https://cdscoonline.gov.in/CDSCO/Drugs. Accessed on 6 June, 2023.
Jaju PB. Effectiveness and safety of isoxsuprine hydrochloride as tocolytic agent in arresting active/threatened preterm labor and its role in maintenance tocolysis: A prospective, open-label study. Am J Perinatol. 2021;38(3):291-5.
Alavi A, Rajaee M, Amirian M, Mahboobi H, Jahanshahi KA, Faghihi A. Effect of maintenance therapy with isoxsuprine in the prevention of preterm labor: Randomized controlled trial. Electron Physician. 2015;7(4):1144.
Jaju PB, Sood A, Chavan V, Devgarha G, Jain S, Kundapur V et al. Practice patterns in the management of PTL in India: a multicentric, retrospective study. Int J Reprod Contracept Obstet Gynecol. 2017;6(12):5306-13.
Dahman HAB. Risk factors associated with preterm birth: A retrospective study in Mukalla Maternity and Childhood Hospital, Hadhramout Coast/Yemen. Sudan J Paediatr. 2020;20(2):99-110.
Phillips C, Velji Z, Hanly C, Metcalfe A. Risk of recurrent spontaneous preterm birth: A systematic review and meta-analysis. BMJ Open. 2017;7(6):e015402.
Suman V, Luther EE. Preterm Labor. In: StatPearls Treasure Island (FL): StatPearls Publishing. 2023.
Samuel TM, Sakwinska O, Makinen K, Burdge GC, Godfrey KM, Silva-Zolezzi I. Preterm birth: A narrative review of the current evidence on nutritional and bioactive solutions for risk reduction. Nutrients. 2019;11(8):1811.
National Collaborating Centre for Women’s and Children’s Health (UK). Preterm Labour and Birth: NICE Guideline, No. 25. Methods, evidence and recommendations. Version 2.0.s London: National Institute for Health and Care Excellence (UK). 2015.
Lacagnina S. The Developmental Origins of Health and Disease (DOHaD). Am J Lifestyle Med. 2020;14(1):47-50.
India: Profile of preterm and low birth weight prevention and care-India 2015. Available at: https://reliefweb.int/report/india/india-profile-preterm-and-low-birth-weight-prevention-and-care. Accessed on 25 July, 2023.
Devi TC, Singh HS. Prevalence and associated risk factors of preterm birth in India: A review. J Public Health Dev. 2021;2:209-26.
Giouleka S, Tsakiridis I, Kostakis N, Koutsouki G, Kalogiannidis I, Mamopoulos A et al. Preterm Labor: A comprehensive review of guidelines on diagnosis, management, prediction and prevention. Obstet Gynecol Surv. 2022;77(5):302-17.
American College of Obstetricians and Gynecologists’ Committee Opinion No. 667: Hospital-based triage of obstetric patients. Obstet Gynecol. 2016b;128(1):e16-9.
American College of Obstetricians and Gynecologists (ACOG). Committee Opinion No. 712: Intrapartum management of intraamniotic infection. Obstet Gynecol. 2017;130(2):e95-101.
Grivell RM, Alfirevic Z, Gyte GM, Devane D. Antenatal cardiotocography for fetal assessment. Cochrane Database Syst Rev. 2015;2015(9):CD007863.
Vogel JP, Chawanpaiboon S, Moller AB, Watananirun K, Bonet M, Lumbiganon P. The global epidemiology of Preterm birth. Best Pract Res Clin Obstet Gynaecol. 2018;52:3-12.
Hughes KM, Kane SC, Haines TP, Sheehan PM. Cervical length surveillance for predicting spontaneous preterm birth in women with uterine anomalies: A cohort study. Acta Obstet Gynecol Scand. 2020;99(11):1519-26.
Berghella V, Hayes E, Visintine J, Baxter JK. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev. 2008;2008(4):CD006843.
Chiossi G, Saade GR, Sibai B, Berghella V. Using cervical length measurement for lower spontaneous preterm birth rates among women with threatened preterm labor. Obstet Gynecol. 2018;132(1):102-6.
American College of Obstetricians and Gynecologists’ (ACOG) Practice Advisory: Updated clinical guidance for the use of progesterone supplementation for the prevention of recurrent preterm birth. April 2023. Available at: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2023/04/updated-guidance-use-of-progesterone-supplementation-for-prevention-of-recurrent-preterm-birth#:~:text=Vaginal%20progesterone%20may%20be%20considered. Accessed on 6 Jun, 2023.
Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3(3):CD004454.
Konar H, Dutta DC. DC Dutta’s Textbook of Gynecology. 8th ed. New Delhi: Jaypee Brothers Medical Publisher’s Ltd; 2020. Available at: https://www.jaypeedigital.com/book/978938958788. Accessed on 6 Jun, 2023.
Giorgino FL, Egan CG. Use of isoxsuprine hydrochloride as a tocolytic agent in the treatment of preterm labour: A systematic review of previous literature. Arzneimittel-jforschung. 2010;60(7):415-20.
Atosiban 37.5 mg/5 ml concentrate for solution for infusion-Summary of Product Characteristics (SmPC). Available at: https://www.medicines. org.uk/emc/product/3262/smpc#gre. Accessed on 9 October 2023.
Revisiting the use of isoxsuprine in preterm labor. Indian Society for the Study of Reproduction and Fertility (ISSRF). Elsevier. 2017.
Jørgensen JS, Weile LK, Lamont RF. Preterm labor: current tocolytic options for the treatment of preterm labor. Expert Opin Pharmacother. 2014;15(5):585-8.
Wilson A, Hodgetts-Morton VA, Marson EJ, Markland AD, Larkai E, Papadopoulou A, et al. Tocolytics for delaying preterm birth: A network meta-analysis (0924). Cochrane Database Syst Rev. 2022;8(8):CD014978.
Duvadilan dosage-Abbott. 2023. Available at: https://www.mims.com/philippines/drug/info/duvadilan/dosage. Accessed on 24 August 2023.
Kavitha M, Malarvizhi KL, Anuradha S, Padmanaban S. Comparison of isoxsuprine 10 mg and 40 mg for the management of preterm mothers: A prospective study. Int J Clin Obstetr Gynaecol. 2018;2(4):13-7
Caffrey AR, Borrelli EP. The art and science of drug titration. Ther Adv Drug Saf. 2021;11:2042098620958910.
Shennan A, Suff N, Jacobsson B, FIGO Working Group for Preterm Birth, Simpson JL et al. FIGO good practice recommendations on magnesium sulphate administration for preterm fetal neuroprotection. Int J Gynecol Obstet. 2021;155(1):31-3.
